BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

Progyny (PGNY)ProgynyConference / presentation

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Mark Livingston, Progyny’s Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on

Open original release

Related news

PGNYProgyny2026-01-12 13:00 EST

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference

PGNYProgyny2026-05-11 14:57 EST

Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

COOThe Cooper Companies2025-12-29 21:15 EST

CooperCompanies to Present at the J.P. Morgan Healthcare Conference

COOThe Cooper Companies2025-08-14 20:15 EST

CooperCompanies to Participate in the Wells Fargo Healthcare Conference

TDOCTeladoc2026-03-03 21:05 EST

Teladoc Health to Participate in Upcoming Investor Conference

SERASera Prognostics2026-02-17 13:05 EST

SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE

TDOCTeladoc2026-03-30 20:30 EST

Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors

View all latest news

Progyny

Progyny is a fertility and family-building benefits company serving employers and their members through specialized reproductive-health services.

Recent company news

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

PGNYProgyny2026-05-11 14:57 EST

Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

PGNYProgyny2026-05-07 20:01 EST

Progyny, Inc. Announces First Quarter 2026 Results

PGNYProgyny2026-04-23 17:56 EST

Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

Stock data

Close
31.59 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States